Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
Apply
FDC Laroprovstat/Rosuvastatin
A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step